MSL
AMED

Mackay Shields LLC’s Amedisys AMED Stock Holding History

Mackay Shields LLC’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,491
Closed -$3.57M – 732
2021
Q1 		$3.57M Sell
13,491
-10,009
-43% -$2.82M 0.03% 555
2020
Q4 		$6.89M Sell
23,500
-5,473
-19% -$1.4M 0.05% 405
2020
Q3 		$6.85M Buy
28,973
+10,273
+55% +$2.34M 0.05% 392
2020
Q2 		$3.71M Sell
18,700
-9,100
-33% -$1.7M 0.03% 501
2020
Q1 		$5.1M Buy
+27,800
New +$4.95M 0.05% 388
2019
Q3 		– Sell
-10,300
Closed -$1.25M – 1397
2019
Q2 		$1.25M Sell
10,300
-6,700
-39% -$795K 0.01% 1067
2019
Q1 		$2.1M Buy
17,000
+500
+3% +$62.8K 0.02% 677
2018
Q4 		$1.93M Buy
+16,500
New +$1.94M 0.02% 681

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Mackay Shields LLC's AMED Position: Q2 2021 in Review

Mackay Shields LLC sold out of Amedisys (AMED) in Q2 2021, closing a stake of 13,491 shares — an estimated $3.57M sold.

Mackay Shields LLC first reported a position in AMED in Q4 2018 and held it in 8 quarters. The position peaked at $6.89M in Q4 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Mackay Shields LLC reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 13,491 Amedisys shares in Q2 2021, an estimated $3.57M.
  • Mackay Shields LLC first reported a position in Amedisys in Q4 2018 and held it in 8 quarters.
  • Mackay Shields LLC's Amedisys position peaked at $6.89M in Q4 2020.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.